A thoughtful approach to growth investing. Our research team assigns Silver ratings to strategies that they have a high conviction will outperform the relevant index, or most peers, over a market ...
Tirzepatide vs semaglutide in obesity; GLP1a use is complicated; HF outcomes; the misuse of meta-analyses in HF; and a breakthrough in HF care are the topics John Mandrola, MD, covers this week.